Literature DB >> 17275746

Regional left atrial voltage in patients with atrial fibrillation.

Gregory M Marcus1, Yanfei Yang, Paul D Varosy, Karen Ordovas, Zian H Tseng, Nitish Badhwar, Byron K Lee, Randall J Lee, Melvin M Scheinman, Jeffrey E Olgin.   

Abstract

BACKGROUND: Regional differences in fibrosis, particularly related to the posterior wall and septum, may be important in atrial fibrillation (AF). Using electroanatomic mapping, voltage can be used as a measure of fibrosis.
OBJECTIVES: The purpose of this study was to determine if patients with AF have disproportionately lower voltage in the septal and posterior walls of the left atrium.
METHODS: Sinus rhythm left atrial electroanatomic maps were used in serial patients presenting for left atrial ablation of AF (8-mm tip). Patients undergoing left atrial mapping for focal atrial tachycardia (AT) were used as a comparison group (4-mm tip). Animal experiments were performed to assess the influence of ablation catheter tip size on voltage amplitude.
RESULTS: The posterior and septal walls exhibited the lowest voltages in both groups. Compared with the anterior wall, there was a 3.78-fold greater odds of finding a low-voltage point (<0.5 mV) in the septum (P <.001) and a 3.37-fold greater odds of finding a low-voltage point in the posterior wall (P <.001) in the AF patients; the proportion of low-voltage points by region were not significantly different in the AT group. In the animal model, the mean voltage obtained from an 8-mm ablation catheter was significantly higher (0.30 +/- 0.17 mV) than that obtained from the same points using a 4-mm catheter (0.22 +/- 0.17, P = .05).
CONCLUSION: Regional differences in voltage are present in patients with atrial arrhythmias, with AF patients exhibiting significantly more low-voltage areas in the septum and posterior walls.

Entities:  

Mesh:

Year:  2006        PMID: 17275746      PMCID: PMC1868443          DOI: 10.1016/j.hrthm.2006.10.017

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  19 in total

1.  Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation.

Authors:  Sander Verheule; Emily Wilson; Thomas Everett; Sujata Shanbhag; Catherine Golden; Jeffrey Olgin
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

2.  Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.

Authors:  Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

3.  Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies.

Authors:  Nassir F Marrouche; Thomas Dresing; Christopher Cole; Dianna Bash; Eduardo Saad; Krzysztof Balaban; Stephen V Pavia; Robert Schweikert; Walid Saliba; Ahmed Abdul-Karim; Ennio Pisano; Raffaele Fanelli; Patrick Tchou; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

4.  Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling.

Authors:  Prashanthan Sanders; Joseph B Morton; Peter M Kistler; Steven J Spence; Neil C Davidson; Azlan Hussin; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

5.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.

Authors:  Koonlawee Nademanee; John McKenzie; Erol Kosar; Mark Schwab; Buncha Sunsaneewitayakul; Thaveekiat Vasavakul; Chotikorn Khunnawat; Tachapong Ngarmukos
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

6.  Electrophysiologic and electroanatomic changes in the human atrium associated with age.

Authors:  Peter M Kistler; Prashanthan Sanders; Simon P Fynn; Irene H Stevenson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

7.  Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation.

Authors:  Rutger J Hassink; H Thomas Aretz; Jeremy Ruskin; David Keane
Journal:  J Am Coll Cardiol       Date:  2003-09-17       Impact factor: 24.094

8.  Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.

Authors:  Koichiro Kumagai; Hideko Nakashima; Hidenori Urata; Naoki Gondo; Kikuo Arakawa; Keijiro Saku
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

9.  Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease.

Authors:  A Boldt; U Wetzel; J Lauschke; J Weigl; J Gummert; G Hindricks; H Kottkamp; S Dhein
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

10.  Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans.

Authors:  Prashanthan Sanders; Joseph B Morton; Neil C Davidson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

View more
  29 in total

1.  Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation.

Authors:  Gautam G Lalani; Amir Schricker; Michael Gibson; Armand Rostamian; David E Krummen; Sanjiv M Narayan
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

Review 2.  Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation.

Authors:  Christopher E Woods; Jeffrey Olgin
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

3.  Comparison of left atrial electrophysiologic abnormalities during sinus rhythm in patients with different type of atrial fibrillation.

Authors:  Yazhou Lin; Bing Yang; Fermin C Garcia; Weizhu Ju; Fengxiang Zhang; Hongwu Chen; Jinbo Yu; Mingfang Li; Kai Gu; Kejiang Cao; David J Callans; Francis E Marchlinski; Minglong Chen
Journal:  J Interv Card Electrophysiol       Date:  2013-10-11       Impact factor: 1.900

4.  Automated Detection of Complex Fractionated Atrial Electrograms In Substrate-Based Atrial Fibrillation Ablation: Better Discrimination with a New Setting of CARTO® Algorithm.

Authors:  Julien Seitz; Jérôme Horvilleur; Jérôme Lacotte; Yamina Mouhoub; Fiorella Salerno; Anouska Moynagh; Darach O H-Ici; Mehran Monchi; Laurence Curel; Andre Pisapia
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 5.  Left Atrial Fibrosis: Role in Atrial Fibrillation Pathophysiology and Treatment Outcomes.

Authors:  David Spragg
Journal:  J Atr Fibrillation       Date:  2013-04-06

6.  Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial.

Authors:  C N Pellegrini; E Vittinghoff; F Lin; S B Hulley; G M Marcus
Journal:  Heart       Date:  2009-01-28       Impact factor: 5.994

Review 7.  Nonpharmacologic management of atrial fibrillation: role of the pulmonary veins and posterior left atrium.

Authors:  Kalyanam Shivkumar; Eric Buch; Noel G Boyle
Journal:  Heart Rhythm       Date:  2009-12       Impact factor: 6.343

8.  Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

Authors:  Dolkun Rahmutula; Gregory M Marcus; Emily E Wilson; Chun-Hua Ding; Yuanyuan Xiao; Agnes C Paquet; Rebecca Barbeau; Andrea J Barczak; David J Erle; Jeffrey E Olgin
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

9.  Long-term outcomes of left anterior fascicular block in the absence of overt cardiovascular disease.

Authors:  Mala C Mandyam; Elsayed Z Soliman; Susan R Heckbert; Eric Vittinghoff; Gregory M Marcus
Journal:  JAMA       Date:  2013-04-17       Impact factor: 56.272

10.  Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

Authors:  Gregory M Marcus; Mary A Whooley; David V Glidden; Ludmila Pawlikowska; Jonathan G Zaroff; Jeffrey E Olgin
Journal:  Am Heart J       Date:  2007-10-25       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.